Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 22520516)

1.

Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: necessary or too hazardous?

Verheugt FW.

Am Heart J. 2012 Apr;163(4):531-4. doi: 10.1016/j.ahj.2012.01.018. No abstract available.

PMID:
22520516
2.

Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.

Pipilis A, Lazaros G, Tsakonas G, Stefanadis C.

Hellenic J Cardiol. 2010 Jul-Aug;51(4):330-7. Review. No abstract available.

3.

Dual antiplatelet therapy and the risk of bleeding.

Ziegelstein RC, Green A, Sauder M.

Arch Intern Med. 2011 Apr 25;171(8):787; reply 787-8. doi: 10.1001/archinternmed.2011.147. No abstract available.

PMID:
21518951
4.

["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].

Wallén H, Agren A, Nekludov M.

Lakartidningen. 2007 Nov 28-Dec 4;104(48):3640-2. Swedish. No abstract available.

PMID:
18193674
6.

Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?

Asencio LA, Huang JJ, Alpert JS.

Am J Med. 2014 Jul;127(7):579-85. doi: 10.1016/j.amjmed.2014.02.030. Epub 2014 Mar 6. Review.

PMID:
24608021
7.

Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".

Tapp LD, Lip GY, Lane DA.

Chest. 2011 Feb;139(2):240-2. doi: 10.1378/chest.10-1102. No abstract available.

PMID:
21285051
8.

Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.

Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX.

Int J Cardiol. 2011 Apr 1;148(1):96-101. doi: 10.1016/j.ijcard.2010.11.019. Epub 2010 Dec 23. Review.

PMID:
21185095
9.

Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.

[No authors listed]

Prescrire Int. 2009 Dec;18(104):272-3. No abstract available.

PMID:
20027714
10.

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.

Rubboli A, Halperin JL, Airaksinen KE, Buerke M, Eeckhout E, Freedman SB, Gershlick AH, Schlitt A, Tse HF, Verheugt FW, Lip GY.

Ann Med. 2008;40(6):428-36. doi: 10.1080/07853890802089786. Review.

PMID:
18608125
11.

Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.

Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ.

Thromb Haemost. 2011 Oct;106(4):572-84. doi: 10.1160/TH11-04-0262. Epub 2011 Jul 25.

PMID:
21785808
12.

Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.

Paikin JS, Mehta SR, Eikelboom JW.

Med J Aust. 2010 May 3;192(9):487-8. No abstract available.

PMID:
20438416
13.

6 steps to safer use of triple therapy. Take care when combining aspirin, Plavix, and warfarin.

[No authors listed]

Harv Heart Lett. 2009 Nov;20(3):3. No abstract available.

PMID:
20614639
15.

"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.

Zhao HJ, Zheng ZT, Wang ZH, Li SH, Zhang Y, Zhong M, Zhang W.

Chest. 2011 Feb;139(2):260-70. doi: 10.1378/chest.09-3083.

PMID:
21285053
16.

Comment: Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

Friesen M.

Ann Pharmacother. 2008 Oct;42(10):1521; author reply 1521. doi: 10.1345/aph.1K591b. Epub 2008 Sep 2. No abstract available.

PMID:
18765833
17.

[Preventing cerebrovascular accidents during atrial fibrillation].

Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A.

Presse Med. 2005 Oct 22;34(18):1315-24. Review. French.

PMID:
16269996
18.

Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.

Blackshear JL, Baker VS, Holland A, Litin SC, Ahlquist DA, Hart RG, Ellefson R, Koehler J.

Arch Intern Med. 1996 Mar 25;156(6):658-60.

PMID:
8629878
19.

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE.

N Engl J Med. 1998 Dec 3;339(23):1665-71.

20.

Triple therapy: triple safety or triple danger?

Dewilde W, Breet N, Ten Berg J.

Am J Cardiol. 2010 Feb 15;105(4):579. doi: 10.1016/j.amjcard.2009.09.051. No abstract available.

PMID:
20152257
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk